198 related articles for article (PubMed ID: 17373218)
21. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
[TBL] [Abstract][Full Text] [Related]
22. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
23. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
[TBL] [Abstract][Full Text] [Related]
24. [Peripheral neuropathy in Anderson-Fabry disease: its physiology, evaluation and treatment].
Politei JM; Pagano MA
Rev Neurol; 2004 May 16-31; 38(10):979-83. PubMed ID: 15175982
[TBL] [Abstract][Full Text] [Related]
25. [Neurological manifestations of Fabry disease].
Mendióroz M; Fernández-Cadenas I; Montaner J
Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
[TBL] [Abstract][Full Text] [Related]
26. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
27. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
28. Natural history and treatment of renal involvement in Fabry disease.
Branton M; Schiffmann R; Kopp JB
J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
[No Abstract] [Full Text] [Related]
29. [Results of enzyme replacement therapy in Fabry disease nephropathy].
Dussol B
Presse Med; 2007 Mar; 36 Spec No 1():1S43-7. PubMed ID: 17546767
[TBL] [Abstract][Full Text] [Related]
30. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
[TBL] [Abstract][Full Text] [Related]
31. Renal complications of Fabry disease.
Basic-Jukic N; Kes P; Coric M; Basic-Kes V
Curr Pharm Des; 2013; 19(33):6046-50. PubMed ID: 23448456
[TBL] [Abstract][Full Text] [Related]
32. Fabry disease: cardiac manifestations and therapeutic options.
Pierre-Louis B; Kumar A; Frishman WH
Cardiol Rev; 2009; 17(1):31-5. PubMed ID: 19092368
[TBL] [Abstract][Full Text] [Related]
33. Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.
Nance CS; Klein CJ; Banikazemi M; Dikman SH; Phelps RG; McArthur JC; Rodriguez M; Desnick RJ
Arch Neurol; 2006 Mar; 63(3):453-7. PubMed ID: 16533976
[TBL] [Abstract][Full Text] [Related]
34. Fabry disease: a treatable lysosomal storage disorder.
Phadke SR; Mandal K; Girisha KM
Natl Med J India; 2009; 22(1):20-2. PubMed ID: 19761154
[TBL] [Abstract][Full Text] [Related]
35. Absence of cornea verticillata in hemizygotes of a novel mutation in fabry disease.
Huerva V; Martín M; Canto LM; Yagüe J
Cornea; 2008 Sep; 27(8):970-2. PubMed ID: 18724168
[TBL] [Abstract][Full Text] [Related]
36. Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy.
Desnick RJ; Wasserstein MP; Banikazemi M
Contrib Nephrol; 2001; (136):174-92. PubMed ID: 11688379
[No Abstract] [Full Text] [Related]
37. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
[TBL] [Abstract][Full Text] [Related]
38. Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: A case report.
Germain DP; Bruneval P; Tran TC; Balouet P; Richalet B; Benistan K
Eur J Med Genet; 2010; 53(2):111-2. PubMed ID: 20045092
[TBL] [Abstract][Full Text] [Related]
39. [Update on the treatment of Fabry's disease: pathophysiological concepts].
Politei JM
Rev Neurol; 2010 Nov; 51(9):561-70. PubMed ID: 20979036
[TBL] [Abstract][Full Text] [Related]
40. [Fabry disease (cardiac lysosomal storage disease) associated with heart failure].
Takenaka T; Tei C
Nihon Rinsho; 2007 May; 65 Suppl 5():460-4. PubMed ID: 17571419
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
